PIPRA - Pre-Interventional Preventive Risk Assessment
  • Home
  • Clinical need
  • Our Solution
  • About us
  • News
  • Contact

PIPRA AG (short for Pre-Interventional Preventive Risk Assessment) is developing a cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery.

Picture
CLINICAL NEED
OUR SOLUTION
ABOUT US

LATEST NEWS

PIPRA wins pitch at the Oxford Saïd Entrepreneurship Forum.
PIPRA wins 1st Brain Innovation Award Read more
PIPRA has been chosen for the "Samsung for Impact Accelerator Program 2020"
Read more on startupticker

PIPRA wins the 2019 EIT Health Wild Card New Ventures competition
Read more

AWARDED BY

Picture
Picture
Picture
Picture
Picture
Picture
Picture

“PIPRA will be a huge advancement compared to what we are doing now. If we get a score, or any kind of measurement, which will distinguish between those people at risk and those who are not at risk - this will be tremendously helpful."

Dr. med. Henry Perschak, Head of the International Medical Center, Klinik Hirslanden Zurich

Picture

“In case of surgery, we all expect to recover fully and fast. The reality is often different. PIPRA is applying cutting edge technology to make surgery for all of us safer. PIPRA is a great idea with a great team to make it happen."

Dr. Jürg Wittwer, CEO Touring Club Schweiz

Picture

“PIPRA represents exactly what I imagine an innovative start-up to be: They transform a challenging visionary idea - with a lot of passion and a highly motivated team - into a product that brings a clear added value for the society. This is what highly motivates me to engage in the Advisory Board."

Dr. sc. Techn. Christof A. Bühler, SCS Super Computing Systems

MEMBERSHIPS

Picture
Picture

SUPPORTING PARTNERS

Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
Picture
​PIPRA AG  |  Josefstrasse 219, 8005 Zurich, Switzerland
Legal disclaimer page
  • Home
  • Clinical need
  • Our Solution
  • About us
  • News
  • Contact